News

McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe ...
McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to ...
WASHINGTON -- McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers ...
McKinsey & Co. has agreed to pay $650 million to resolve a Justice Department investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to ...
McKinsey & Company, a consulting firm, has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...
McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Vir… ...
WASHINGTON — McKinsey & Company, a consulting firm, has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court ...
McKinsey & Company agrees to a $650 million settlement over its role in advising Purdue Pharma on opioid sales, avoiding criminal charges under specific conditions. Skip to content NOWCAST WPBF 25 ...
McKinsey & Company, a consulting firm, has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in ...
McKinsey & Company agrees to $650M settlement over its role in ... to deter us from the twin goals of using settlement dollars for opio ... to settle federal probe over opioids.